# Nitto Avecia Pharma Services, Inc. - Inspection Records

Source: https://www.keypedia.com/companies/nitto-avecia-pharma-services-inc/70750fbf-f816-44e6-aeea-e31b27478b84

> Inspection records and compliance data for Nitto Avecia Pharma Services, Inc. in Irvine, California. Access full analysis and detailed observations.

---

## Details

- Name: Nitto Avecia Pharma Services, Inc.
- FEI Number: 3012971227
- City: Irvine
- State: California
- Country Name: United States
- Address Line 1: 10 Vanderbilt
- Zip Code: 92618
- Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, PACK, REPACK

## Related Documents

- [FDA Inspection 1279210 - Nitto Avecia Pharma Services, Inc. - 2025-07-25](https://www.keypedia.com/records/fda_inspections/nitto-avecia-pharma-services-inc/1bbaf13c-7ea5-4f33-b74a-1380e1198f70) — source: FDA, date: July 25, 2025
- [FDA Inspection 1279210 - Nitto Avecia Pharma Services, Inc. - 2025-07-25](https://www.keypedia.com/records/fda_inspections/nitto-avecia-pharma-services-inc/b0126f6f-d594-4062-9af6-93553b87f76a) — source: FDA, date: July 25, 2025
- [FDA Inspection 1279210 - Nitto Avecia Pharma Services, Inc. - 2025-07-25](https://www.keypedia.com/records/fda_inspections/nitto-avecia-pharma-services-inc/aed2547e-f607-4ccb-9712-cd6e0e5d8bee) — classification: No Action Indicated (NAI), source: FDA, date: July 25, 2025
- [FDA Inspection 1279210 - Nitto Avecia Pharma Services, Inc. - 2025-07-25](https://www.keypedia.com/records/fda_inspections/nitto-avecia-pharma-services-inc/b52f8040-90ed-46af-b162-1e8167e5a831) — classification: No Action Indicated (NAI), source: FDA, date: July 25, 2025
- [FDA Inspection 1220658 - Nitto Avecia Pharma Services, Inc. - 2023-09-22](https://www.keypedia.com/records/fda_inspections/nitto-avecia-pharma-services-inc/b451d987-e5ea-41d0-ba06-05f294a68fb2) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 22, 2023
- [483 - Nitto Avecia Pharma Services, Inc. - 2023-09-18](https://www.keypedia.com/records/483/nitto-avecia-pharma-services-inc/4bbe0fcc-fc6d-4cd7-830e-ce3bcce6fb5a) — source: FDA, date: September 18, 2023
- [483 - Nitto Avecia Pharma Services, Inc. - 2020-01-24](https://www.keypedia.com/records/483/nitto-avecia-pharma-services-inc/68c42b34-1b01-4013-a3d4-d115b1a05740) — source: FDA, date: January 24, 2020
- [FDA Inspection 1116308 - Nitto Avecia Pharma Services, Inc. - 2020-01-24](https://www.keypedia.com/records/fda_inspections/nitto-avecia-pharma-services-inc/7f58b95d-2a36-4247-8e45-9c7ba96b1e1a) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 24, 2020
- [EIR - Nitto Avecia Pharma Services, Inc. - 2019-09-06](https://www.keypedia.com/records/eir/nitto-avecia-pharma-services-inc/1ba19846-b0eb-47eb-9047-b05d3b192153) — source: FDA, date: September 6, 2019
- [EIR - Nitto Avecia Pharma Services, Inc. - 2019-09-06](https://www.keypedia.com/records/eir/nitto-avecia-pharma-services-inc/72123f93-991a-478a-bcc1-551bdc8a6372) — source: FDA, date: September 6, 2019
- [FDA Inspection 1103011 - Nitto Avecia Pharma Services, Inc. - 2019-09-06](https://www.keypedia.com/records/fda_inspections/nitto-avecia-pharma-services-inc/f0e69d85-89ad-4f4c-b63d-19a11e081b56) — classification: No Action Indicated (NAI), source: FDA, date: September 6, 2019
- [EIR - Nitto Avecia Pharma Services, Inc. - 2019-05-24](https://www.keypedia.com/records/eir/nitto-avecia-pharma-services-inc/2daae0d2-7fc7-4333-80fd-eb60007f0208) — source: FDA, date: May 24, 2019
- [FDA Inspection 1011375 - Nitto Avecia Pharma Services, Inc. - 2017-04-21](https://www.keypedia.com/records/fda_inspections/nitto-avecia-pharma-services-inc/20a13d9e-01dd-4da5-992a-d94d25b49fd1) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 21, 2017
- [FDA Inspection 921085 - Nitto Avecia Pharma Services, Inc. - 2015-04-03](https://www.keypedia.com/records/fda_inspections/nitto-avecia-pharma-services-inc/3c82c4fc-6519-4ff0-a2dd-0572e96da560) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 3, 2015
- [FDA Inspection 915555 - Nitto Avecia Pharma Services, Inc. - 2015-02-20](https://www.keypedia.com/records/fda_inspections/nitto-avecia-pharma-services-inc/b5b29701-9625-4d2c-a87a-8f460ea57f9d) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 20, 2015

## Related Companies

- [Bioreliance Corporation](https://www.keypedia.com/companies/bioreliance-corporation/08d3dc20-6c7e-4f04-bb98-bbc868e70000)
- [Alcami Carolinas Corporation](https://www.keypedia.com/companies/alcami-carolinas-corporation/bc876747-1f37-4ea6-9e86-c152c19f219e)
- [Associates of Cape Cod, Inc.](https://www.keypedia.com/companies/associates-of-cape-cod-inc/c3c3c25d-3eec-4ab0-826d-a9c915ae89d2)
- [Certified Laboratories LLC](https://www.keypedia.com/companies/certified-laboratories-llc/d411cf88-a1cd-4155-a3b8-e68ead073add)
- [Q LABS, LLC](https://www.keypedia.com/companies/q-labs-llc/3923e3f2-bd54-4e3a-b482-901a7807f845)
- [Microbac Laboratories, Inc.](https://www.keypedia.com/companies/microbac-laboratories-inc/89e9b7d6-bb6e-4614-b79a-bf0cd57cd79a)
- [Laboratory Service Inc.](https://www.keypedia.com/companies/laboratory-service-inc/33bbec58-42fb-442e-afe6-06b81be5bf1d)
- [Encompass Pharmaceutical Services Inc.](https://www.keypedia.com/companies/encompass-pharmaceutical-services-inc/42c093ab-f3bc-421b-8622-2450df89f843)
- [Element Materials Technology Boston - Acton Inc.](https://www.keypedia.com/companies/element-materials-technology-boston-acton-inc/24258d5a-8309-4e67-90f1-adda6124441c)
- [ALS Group USA, Corp](https://www.keypedia.com/companies/als-group-usa-corp/6d3305d4-76a4-4d57-8ed6-1e636d486309)

## Related Officers

- [issuing_officer](https://www.keypedia.com/people/lixia-cai/4eadd29b-3175-4ae4-92bf-0f16e385c8fc)
- [recipient](https://www.keypedia.com/people/violette-akopian/6e03cd56-9c8f-486f-8f04-8af0a4065d86)
- [company_representative](https://www.keypedia.com/people/adam-fox/73741c7d-64d6-4630-a0cc-c33a114cab81)
- [company_representative](https://www.keypedia.com/people/yvette-tanner/7825c08a-073a-4edb-ae06-44170fbfb5b5)